AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...

AP-101 is a first-in-class Phase 3-ready antibody targeting misfolded SOD1 in SOD1-ALS and sporadic ALS Phase 2 findings further demonstrate clinically meaningful disease modification and prolonged ...

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines ...

Scientists say aging may expose decades of hidden damage, helping trigger diseases that seem to appear out of nowhere in ...

LEHI, Utah, June 15, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting inflammasome-driven disease biology, today ...

What is the Walter Panas valedictorian’s secret for getting top grades? Hard work — and YouTube. “I watch videos” to prepare ...

Delivering another major blow to LGBTQ rights, the Supreme Court on Tuesday upheld state laws that ban transgender athletes ...

Studies of genetics conducted in yeast cells, human neurons, mice or other model systems often reveal networks of genes that ...

Biology has clever ways to mask the effects of potentially harmful gene mutations. Scientists are investigating how this ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The outdoors feels more dangerous than ever in Grounded 2, and many ...

The US Supreme Court ruled Tuesday that barring transgender students from participating in girls' school sports teams is ...

ARTAN Bio has developed a novel engineered suppressor tRNA system (ARTAN-102) designed to selectively recognize disease-causing nonsense codons and restore normal protein translation. Unlike ...